WS #15330
TSMC's negotiations with Elon Musk over a 'Terafab' in Texas represent a significant competitive threat to Intel's foundry ambitions, causing Intel to fall 4% while TSMC attracted $9.6 million in bullish put options. While BNP Paribas raised targets for both chips on AI demand, the Intel narrative is now split between AI growth and foundry execution risk. This development highlights the intensifying geopolitical and commercial competition in semiconductor manufacturing.
TSMC Intel Terafab Competition
TSMC's negotiations with Elon Musk over a 'Terafab' in Texas represent a significant competitive threat to Intel's foundry ambitions, causing Intel to fall 4% while TSMC attracted $9.6 million in bullish put options. While BNP Paribas raised targets for both chips on AI demand, the Intel narrative is now split between AI growth and foundry execution risk. This development highlights the intensifying geopolitical and commercial competition in semiconductor manufacturing.